Multiplex peptide microarray profiling of antibody reactivity against neglected tropical diseases derived B-cell epitopes for serodiagnosis in Zimbabwe.
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2022
2022
Historique:
received:
22
07
2021
accepted:
08
07
2022
entrez:
22
7
2022
pubmed:
23
7
2022
medline:
27
7
2022
Statut:
epublish
Résumé
Peptides (B-cell epitopes) have broad applications in disease diagnosis and surveillance of pathogen exposure. In this framework, we present a pilot study to design and produce a peptide microarray for the integrated surveillance of neglected tropical diseases. The peptide microarray was evaluated against peptides derived from Ascaris lumbricoides, Necator americanus, Schistosoma haematobium, Schistosoma mansoni, Trichuris trichiura, Bacillus anthracis, Mycobacterium leprae, Wuchereria bancrofti, Rabies lyssavirus, Chlamydia trachomatis and Trypanosoma brucei. S. haematobium was diagnosed using the urine filtration technique. S. mansoni, A. lumbricoides, N. americanus and T. trichiura were diagnosed using the Kato Katz and formal ether concentration techniques. Immunogenic peptides were retrieved from the Tackling Infection to Benefit Africa infectious diseases epitope microarray. Further peptides were predicted using ABCpred. IgG and IgM reactivity against the derived peptides were evaluated using peptide microarray multiplex immunoassays. Positive response was defined as fluorescence intensity ≥ 500 fluorescence units. Immunodominant peptides were identified using color-coded heat maps and bar graphs reflecting the obtained fluorescence signal intensities. Receiver Operating Characteristic analysis and Mann-Whitney-U test were performed to determine the diagnostic validity of the peptides. Species-specific responses with at least one peptide derived from each NTD pathogen were observed. The reactive peptides included; for S. haematobium, XP_035588858.1-206-220 and XP_035588858.1-206-220 immunodominant for IgG and IgM respectively, for S. mansoni, P20287.1-58-72 immunodominant for both antibodies and for T. trichiura, CDW52482.1-326-340 immunodominant for IgG and CDW57769.1-2017-2031 and CDW57769.1-1518-1532 immunodominant for IgM. According to ROC analysis most of the peptides selected were inaccurate; with AUC < 0.5. Some peptides had AUC values ranging from 0.5 to 0.5875 for both IgM and IgG suggesting no discrimination. Multiplex peptide microarrays are a valuable tool for integrated NTDs surveillance and for screening parasites exposure in endemic areas. Species sero-reactivity observed in the study maybe indicative of exposure to the different NTDs parasites. However, although peptides with the least cross reactivity were selected there is need to validate the sero-reactivity with recombinant antigens and immune-blotting techniques such as western blotting.
Identifiants
pubmed: 35867689
doi: 10.1371/journal.pone.0271916
pii: PONE-D-21-23533
pmc: PMC9307155
doi:
Substances chimiques
Epitopes, B-Lymphocyte
0
Immunoglobulin G
0
Immunoglobulin M
0
Peptides
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0271916Subventions
Organisme : Department of Health
Pays : United Kingdom
Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
J Thorac Oncol. 2010 Sep;5(9):1315-6
pubmed: 20736804
Int J Parasitol. 2012 Aug;42(9):797-800
pubmed: 22846784
J Trop Med. 2018 Nov 6;2018:7218534
pubmed: 30532789
Ophthalmic Epidemiol. 2018 Dec;25(sup1):181-191
pubmed: 28532208
Infect Dis Poverty. 2020 Jan 28;9(1):10
pubmed: 31987053
PLoS Negl Trop Dis. 2015 May 14;9(5):e0003752
pubmed: 25973845
Exp Parasitol. 2017 Aug;179:36-42
pubmed: 28655585
Bioconjug Chem. 2004 Mar-Apr;15(2):317-25
pubmed: 15025527
PLoS Negl Trop Dis. 2010 Jul 20;4(7):e754
pubmed: 20651931
BMC Infect Dis. 2020 Oct 29;20(1):803
pubmed: 33121458
Front Immunol. 2021 Mar 23;12:629185
pubmed: 33833755
Clin Microbiol Infect. 2017 May;23(5):335.e1-335.e5
pubmed: 28259548
Int J Parasitol. 2014 Oct 1;44(11):765-74
pubmed: 24992655
Trends Parasitol. 2006 Aug;22(8):363-6
pubmed: 16798088
PLoS Negl Trop Dis. 2014 Aug 14;8(8):e3014
pubmed: 25121489
Mol Cell Probes. 2017 Feb;31:2-21
pubmed: 27986555
Mol Cell Proteomics. 2016 Apr;15(4):1360-80
pubmed: 26831522
J Immunol Methods. 2012 Jan 31;375(1-2):46-56
pubmed: 21963950
Proteins. 2006 Oct 1;65(1):40-8
pubmed: 16894596
Sci Rep. 2018 Mar 16;8(1):4701
pubmed: 29549361
Am J Trop Med Hyg. 2020 Jan;102(1):164-176
pubmed: 31769388
Expert Rev Anti Infect Ther. 2013 Nov;11(11):1237-58
pubmed: 24127662
Infect Immun. 2001 Apr;69(4):2396-401
pubmed: 11254599
Trop Med Infect Dis. 2017 Aug 05;2(3):
pubmed: 30270893
Vaccine. 2010 Jun 17;28(28):4529-37
pubmed: 20450869
Methods Mol Biol. 2016;1403:569-82
pubmed: 27076154
Tropenmed Parasitol. 1982 Dec;33(4):227-8
pubmed: 7164164
Front Immunol. 2018 Oct 09;9:2331
pubmed: 30356796
Trans R Soc Trop Med Hyg. 2016 Nov 1;110(11):657-663
pubmed: 28100811
Parasite Immunol. 2014 Sep;36(9):428-38
pubmed: 25201406
PLoS Negl Trop Dis. 2017 May 19;11(5):e0005616
pubmed: 28542223